J
Jesper Damsgaard Gunst
Researcher at Aarhus University Hospital
Publications - 35
Citations - 756
Jesper Damsgaard Gunst is an academic researcher from Aarhus University Hospital. The author has contributed to research in topics: Medicine & Immune system. The author has an hindex of 10, co-authored 26 publications receiving 286 citations. Previous affiliations of Jesper Damsgaard Gunst include Aarhus University.
Papers
More filters
Journal ArticleDOI
Efficacy of the TMPRSS2 inhibitor camostat mesilate in patients hospitalized with Covid-19-a double-blind randomized controlled trial.
Jesper Damsgaard Gunst,Nina Breinholt Stærke,Marie H. Pahus,Lena Hagelskjaer Kristensen,Jacob Bodilsen,Nicolai Lohse,Nicolai Lohse,Lars Skov Dalgaard,Dorthe Brønnum,Ole Fröbert,Bo Langhoff Hønge,Isik Somuncu Johansen,Ida Monrad,Christian Erikstrup,Christian Erikstrup,Regitze Rosendal,Emil Vilstrup,Theis Mariager,Dorthe Gaby Bove,Rasmus Offersen,Shakil Shakar,Sara Cajander,Nis Pedersen Jørgensen,Sajitha S. Sritharan,Peter Breining,Søren Jespersen,Klaus Leth Mortensen,Mads L. Jensen,Lilian Kolte,Giacomo S. Frattari,Carsten Schade Larsen,Merete Storgaard,Lars Peter Nielsen,Lars Peter Nielsen,Martin Tolstrup,Martin Tolstrup,Eva Aggerholm Sædder,Eva Aggerholm Sædder,Lars Østergaard,Lars Østergaard,Hien T. T. Ngo,Morten Hasselstrøm Jensen,Morten Hasselstrøm Jensen,Jesper F Højen,Mads Kjolby,Ole Schmeltz Søgaard,Ole Schmeltz Søgaard +46 more
TL;DR: In this article, the transmembrane protease serine serine 2 (TMPRSS2) is essential for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
Journal ArticleDOI
Camostat mesylate against SARS-CoV-2 and COVID-19-Rationale, dosing and safety.
Peter Breining,Anne Lier Frølund,Jesper F Højen,Jesper Damsgaard Gunst,Jesper Damsgaard Gunst,Nina Breinholt Stærke,Nina Breinholt Stærke,Eva Aggerholm Sædder,Eva Aggerholm Sædder,Manuel Cases‐Thomas,Paul Little,Lars Peter Nielsen,Lars Peter Nielsen,Ole Schmeltz Søgaard,Ole Schmeltz Søgaard,Mads Kjolby +15 more
TL;DR: Camostat mesylate, an orally available well‐known serine protease inhibitor, is a potent inhibitor of TMPRSS2 and has been hypothesized as a potential antiviral drug against COVID‐19, and clinical trials are currently ongoing to test whether this well-known drug could be repurposed and utilized to combat the current pandemic.
Journal ArticleDOI
SARS-CoV-2 persistence is associated with antigen-specific CD8 T-cell responses.
Line K. Vibholm,Stine S F Nielsen,Marie H. Pahus,Giacomo S. Frattari,Rikke Olesen,Rebecca Andersen,Ida Monrad,Anna H. F. Andersen,Michelle M. Thomsen,Christina V. Konrad,Sidsel D. Andersen,Jesper F Højen,Jesper Damsgaard Gunst,Lars Østergaard,Lars Østergaard,Ole Schmeltz Søgaard,Ole Schmeltz Søgaard,Mariane H. Schleimann,Martin Tolstrup,Martin Tolstrup +19 more
TL;DR: In this paper, a cohort study was conducted between April 3rd-July 9th 2020, recruiting COVID-19 recovered individuals that were symptom-free for at least 14 days.
Journal ArticleDOI
Results of a Multinational Study Suggest the Need for Rapid Diagnosis and Early Antiviral Treatment at the Onset of Herpetic Meningoencephalitis
Hakan Erdem,Yasemin Cag,Derya Ozturk-Engin,Sylviane Defres,Sylviane Defres,Selçuk Kaya,Lykke Larsen,Mario Poljak,Bruno Baršić,Xavier Argemi,Signe Maj Sørensen,Anne Lisbeth Bohr,Pierre Tattevin,Jesper Damsgaard Gunst,Lenka Baštáková,Matjaž Jereb,Isik Somuncu Johansen,Oguz Karabay,Abdullah Umut Pekok,Oğuz Reşat Sipahi,Mahtab Chehri,Guillaume Béraud,Ghaydaa A. Shehata,Rosa Fontana Del Vecchio,Mauro Maresca,Hasan Karsen,Gonul Sengoz,Mustafa Sunbul,Gulden Yilmaz,Hava Yilmaz,Ahmad Sharif-Yakan,Souha S. Kanj,Emine Parlak,Filiz Pehlivanoglu,Fatime Korkmaz,Süheyla Kömür,Sukran Kose,Mehmet Ulug,Sibel Bolukcu,Seher Ayten Coskuner,Nevin Ince,Yasemin Akkoyunlu,Gulistan Halac,Elif Sahin-Horasan,Hulya Tireli,Gamze Kilicoglu,Akram Al-Mahdawi,Salih Atakan Nemli,Asuman Inan,Seniha Senbayrak,Jean-Paul Stahl,Haluk Vahaboglu +51 more
TL;DR: It is suggested that rapid diagnosis and early administration of antiviral treatment in HME patients are keys to a favorable outcome.
Journal ArticleDOI
Persistent Symptoms in Patients Recovering From COVID-19 in Denmark
Steffen Leth,Jesper Damsgaard Gunst,Jesper Damsgaard Gunst,Victor Dahl Mathiasen,Kristoffer Skaalum Hansen,Ole Schmeltz Søgaard,Ole Schmeltz Søgaard,Lars Østergaard,Lars Østergaard,Søren Jensen-Fangel,Merete Storgaard,Jane Agergaard +11 more
TL;DR: In this paper, patients with positive polymerase chain reaction (PCR) test for severe acute respiratory syndrome coronavirus 2 who were hospitalized at the Department of Infectious Diseases, Aarhus University Hospital, Denmark, in the period from March 11 to May 15 were offered follow-up after hospitalization On admission, a comprehensive symptom and medical history was collected, including demographic characteristics, duration of symptoms, comorbidities, and concomitant medications.